일차성 사구체신염에 대한 저령탕 병용요법의 효능 : 체계적 문헌고찰 및 메타 분석
Adjuvant Therapy Efficacy of Herbal Medicine Zeo Lyung Tang (Zhu Ling Decoction) for Primary Glomerulonephritis: Systematic Review and Meta-Analysis
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: The aim of this study was to systematically evaluate the clinical therapeutic effects and safety of the Zeo lyung tang (ZLT) on primary glomerulonephritis (PGN). Methods: The MEDLINE, EMBASE, PubMed, CENTRAL, CNKI, RISS, NDSL, KISS, and OASIS databases were searched for randomized controlled trials (RCTs) testing the effects of ZLT on PGN. The Cochrane collaboration bias risk assessment scale was used to evaluate the methodological quality of the included studies. RevMan 5.3 software was used for data analysis. Results: Ten RCTs involving 781 patients were included in the review. Compared with conventional Western medicine (WM) therapy alone, a combination treatment of ZLT and WM improved the total effective rate (RR=1.24; 95%CI [1.16, 1.33]; p<0.00001), reduce the blood urea nitrogen (BUN; MD=-1.05; 95%CI [-1.32, -0.78]; p<0.00001) and the 24-hour urinary protein (MD=-0.38; 95%CI [-0.46, -0.29]; p<0.00001). Conclusions: The combination of ZLT with WM has therapeutic effects on PGN, and it has advantages over WM treatment alone in reducing BUN and 24-hour urinary protein. However, due to the low quality of the included studies and the small sample sizes, additional research is needed in this area.
Abstract
Objectives: The aim of this study was to systematically evaluate the clinical therapeutic effects and safety of the Zeo lyung tang (ZLT) on primary glomerulonephritis (PGN). Methods: The MEDLINE, EMBASE, PubMed, CENTRAL, CNKI, RISS, NDSL, KISS, and OASIS databases were searched for randomized controlled trials (RCTs) testing the effects of ZLT on PGN. The Cochrane collaboration bias risk assessment scale was used to evaluate the methodological quality of the included studies. RevMan 5.3 software was used for data analysis. Results: Ten RCTs involving 781 patients were included in the review. Compared with conventional Western medicine (WM) therapy alone, a combination treatment of ZLT and WM improved the total effective rate (RR=1.24; 95%CI [1.16, 1.33]; p<0.00001), reduce the blood urea nitrogen (BUN; MD=-1.05; 95%CI [-1.32, -0.78]; p<0.00001) and the 24-hour urinary protein (MD=-0.38; 95%CI [-0.46, -0.29]; p<0.00001). Conclusions: The combination of ZLT with WM has therapeutic effects on PGN, and it has advantages over WM treatment alone in reducing BUN and 24-hour urinary protein. However, due to the low quality of the included studies and the small sample sizes, additional research is needed in this area.
참고문헌 (30)
- Sethi S, "Standardized classification and reporting of glomerulonephritis", Nephrol Dial Transplant, 34(2), pp.193~199 (2019)
- McGrogan A, "The incidence of primary glomerulonephritis worldwide:a systematic review of the literature", Nephrol Dial Transplant, 26(2), pp.414~430 (2011)
- Floege J, "Primary glomerulonephritides", Lancet, 387(10032), pp.2036~2048 (2016)
- Chou YH, "Clinical outcomes and predictors for ESRD and mortality in primary GN", Clin J Am Soc Nephrol, 7(9), pp.1401~1408 (2012)
- Sethi S, "Mayo Clinic", Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN, 2016, pp.27(5), 1278~1287
- Radhakrishnan J, "The KDIGO practice guideline on glomerulonephritis:reading between the (guide)lines--application to the individual patient", Kidney Int, 82(8), pp.840~856 (2012)
- Jiang S, "The primary glomerulonephritides:a systems biology approach", Nat Rev Nephrol, 9(9), pp.500~512 (2013)
- Wang YJ, "Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3:a multicenter double-blinded randomized controlled trial", J Ethnopharmacol, 139(3), pp.757~764 (2012)
- Huang KC, "Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan:A Nationwide Retrospective Population- Based Cohort Study", Front Pharmacol, 9, pp.1117~ (2018)
- Zhong Y, "Recent Advances in Traditional Chinese Medicine for Kidney Disease", Am J Kidney Dis, 66(3), pp.513~522 (2015)
- Higgins JPT, "Cochrane handbook for systematic reviews of interventions (Version 5.1.0)", The Cochrane Collaboration, ~ (2011)
- Moher D, "Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement", Ann Intern Med, 151(4), pp.264~ (2009)
- The Nordic Cochrane Centre, "Review Manager (RevMan) Copenhagen", The Nordic Cochrane Centre, The Cochrane Collaboration, ~ (2014)
- Higgins JPT, "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials", BMJ, 343, pp.d5928~ (2011)
- Cen WX, "Clinical Observation on Treatment of 43 Cases of Chronic Glomerulonephritis with Liuwei Dihuang Decoction and Zhuling Decoction", Hunan Journal of Traditional Chinese Medicine, 29(11), pp.43~44 (2013)
- Chen J, "Study on the Effect of Compound Zhuling Decoction in the Treatment of Chronic Glomerulonephritis", Journal of China Prescription Drug, 16(10), pp.103~104 (2018)
- Guan XD, "Analysis of the therapeutic effect of Compound Zhuling Decoction on chronic glomerulonephritis", Chinese Medicine Modern Distance Education of China, 15(5), pp.94~95 (2017)
- Ma WZ, "Effect of Compound Zhuling Decoction on Urinary Protein Level and Complications in Patients with Chronic Glomerulonephritis", J Med Theor & Prac, 33(6), pp.925~927 (2020)
- Quan SJ, "Clinical Study on the Effect of Jiawei Zhuling Decoction on Membranoproliferative Glomerulonephritis", Journal of Traditional Chinese Medicine, 42(5), pp.282~284 (2001)
- Su XH, "Observation on Curative Effect of Modified Zhuling Decoction in Treating 30 Cases of Chronic Glomerulonephritis", Chin J of Clinical Rational Drug Use, 3(19), pp.58~59 (2010)
- Xi YP, "Effect of Modified Zhuling Decoction on Chronic Glomerulonephritis", Seek Medical And Ask The Medicine, 11(10), pp.162~163 (2013)
- Xu WM, "Clinical Observation on Treatment of Chronic Glomerulonephritis with Integrative Chinese-Western Medicine", Asia-Pacific Traditional Medicine, 11(2), pp.74~75 (2015)
- Yang XB, "Study on the Effect of Compound Zhuling Decoction in the Treatment of Chronic Glomerulonephritis", China Medical Devices, 32(S2), pp.75~76 (2017)
- Zhu ZJ, "Treatment of 57 Cases of Chronic Glomerulonephritis with Zhuling Decoction", Hunan Journal of Traditional Chinese Medicine, 19(2), pp.45~ (2003)
- Zhang J, "Efficacy and safety of rituximab therapy for membranous nephropathy:a meta-analysis", Eur Rev Med Pharmacol Sci, 22(22), pp.8021~8029 (2018)
- Cheng J, "ACEI", ARB therapy for IgA nephropathy:a meta analysis of randomised controlled trials, 2009, pp.63(6), 880~888
- Su K, "The progression about clinical and experimental study of polypore umbellate decoction application in chronic kidney", China journal of Chinese medicine, 25(148), pp.589~592 (2010)
- Wang Z, "Research progress on the diagnosis and treatment of Zhuling decoction", Chinese medicine modern distance education of china, 15(3), pp.143~145 (2017)
- Yang B, "Nephrotoxicity and Chinese Herbal Medicine", Clin J Am Soc Nephrol, 13(10), pp.1605~1611 (2018)
- Hsieh CF, "Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease:results from a population-based follow-up study", BMJ Open, 4(2), pp.e004033~ (2014)